Key stats
About ProShares UltraShort Nasdaq Biotechnology
Home page
Inception date
Apr 7, 2010
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
ProShare Advisors LLC
Distributor
SEI Investments Distribution Co.
BIS is one available fund that provides exposure to the biotech space aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Cash
Bonds, Cash & Other100.00%
Cash96.54%
Government3.46%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
BIS last dividends amounted to 0.13 USD. The quarter before, the issuer paid 0.21 USD in dividends, which shows a 55.71% decrease.
BIS assets under management is 2.86 M USD. It's fallen 23.23% over the last month.
BIS fund flows account for −430.35 K USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, BIS pays dividends to its holders with the dividend yield of 3.44%. The last dividend (Apr 1, 2025) amounted to 0.13 USD. The dividends are paid quarterly.
BIS shares are issued by ProShare Advisors LLC under the brand ProShares. The ETF was launched on Apr 7, 2010, and its management style is Passive.
BIS expense ratio is 0.95% meaning you'd have to pay 0.95% of your investment to help manage the fund.
BIS follows the NASDAQ / Biotechnology. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
BIS invests in cash.
BIS price has risen by 0.16% over the last month, and its yearly performance shows a 9.02% increase. See more dynamics on BIS price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −9.54% over the last month, have fallen by −9.54% over the last month, showed a 19.56% increase in three-month performance and has increased by 13.80% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −9.54% over the last month, have fallen by −9.54% over the last month, showed a 19.56% increase in three-month performance and has increased by 13.80% in a year.
BIS trades at a premium (0.08%) meaning the ETF is trading at a higher price than the calculated NAV.